4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SETBP1 and NRAS mutations are frequent events in post-myeloproliferative neoplasm acute myeloid leukemia (post-MPN AML) lacking JAK-STAT activating mutations
    Meeting Abstract

    Menghrajani, K.; Rapaport, F.; McNamara, C. J.; Devlin, S. M.; Famulare, C.; Patel, M.; Medina, J.; Sandy, L.; Kosiorek, H.; Singer Weinberg, R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Targeting cell non-autonomous MAPK activation as a novel therapeutic strategy in myeloproliferative neoplasms
    Meeting Abstract

    Meyer, S. C.; Ghosh, N.; Stivala, S.; Baerenwaldt, A.; Hao-Shen, H.; Dirnhofer, S.; Dettmer, M. S.; Simillion, C.; Chiu, S.; Keller, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling (CGP) informs molecular diagnosis, prognosis, and therapeutic decision-making for patients with angioimmunoblastic T-cell lymphoma (AITL)
    Meeting Abstract

    Morley, S.; He, J.; Intlekofer, A. M.; Bailey, M.; Nahas, M.; Heilmann, A.; Chudnovsky, Y.; Fabrizio, D.; Ali, S. M.; Lipson, D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Successful treatment of mature T-cell lymphoma with allogeneic stem cell transplantation: The largest multicenter retrospective analysis
    Meeting Abstract

    Mehta-Shah, N.; Teja, S.; Tao, Y.; Cashen, A. F.; Beaven, A.; Alpdogan, O.; Porcu, P.; Wiggin, M.; Song, K. W.; Alzahrani, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Response to the EZH2 inhibitor tazemetostat is independent of cell of origin determined via Hans imunohistochemistry or nanostring lymphoma subtyping test in EZH2 wild-type DLBCL patients
    Meeting Abstract

    McDonald, A. A.; Morschhauser, F.; Ribrag, V.; McKay, P.; Salles, G.; Tilly, H.; Schmitt, A.; Gerecitano, J.; Dickinson, M. J.; Assouline, S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genome-wide association study for Waldenström macroglobulinemia identifies novel susceptibility loci
    Meeting Abstract

    McMaster, M. L.; Berndt, S. I.; Zhang, J.; Slager, S. L.; Li, S.; Brown, E. E.; Ekstrom-Smedby, K.; Kleinstern, G.; Zhu, B.; Chung, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Advanced forms of the myeloproliferative neoplasms are associated with chromosomal abnormalities involving 1q and 12q: Implicating MDM2 and MDM4 in disease progression
    Meeting Abstract

    Marcellino, B.; Tripodi, J.; Lu, M.; Kosiorek, H.; Mascarenhas, J.; Rampal, R. K.; Dueck, A. C.; Hoffman, R.; Najfeld, V.
    Blood (2017)

    Fulltext@MSK | Save
  • Stroke in pediatric sickle cell disease in Sub-Saharan Africa: Systematic review and estimated prevalence
    Meeting Abstract

    Marks, L. J.; Munube, D.; Kasirye, P.; Mupere, E.; Jin, Z.; LaRussa, P.; Idro, R.; Green, N. S.
    Blood (2017)

    Fulltext@MSK | Save
  • Melflufen therapy for relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: A report on early efficacy
    Meeting Abstract

    Mateos, M. V.; Bladé, J.; Larocca, A.; Oriol, A.; Rodriguez, P.; Alegre, A.; Cavo, M.; Moreb, J. S.; Paner, A.; Gabrail, N.; more...
    Blood (2017)

    Fulltext@MSK | Save